Dinuclear silver and gold bisNHC complexes as drug candidates for cancer therapy

被引:9
|
作者
Quintana, Mireia [1 ]
Rodriguez-Rius, Alba [1 ]
Velle, Alba [2 ]
Vives, Sonia [1 ]
Sanz Miguel, Pablo J. [2 ]
Triola, Gemma [1 ]
机构
[1] CSIC, Dept Quim Biol, Inst Quim Avanzada Cataluna IQAC, Jordi Girona 18-26, Barcelona 08034, Spain
[2] Univ Zaragoza, Inst Sintesis Quim & Catalisis Homogenea ISQCH, Dept artarnento Quim Inorgan, CSIC, Zaragoza 50009, Spain
关键词
Gold; Silver; N -heterocyclic carbene; Ovarian cancer; Oxidative stress; THIOREDOXIN REDUCTASE; CARBENE COMPLEXES; CELL-LINES; INHIBITION; APOPTOSIS; MECHANISMS; EXPRESSION; REACTIVITY; PLATINUM; SYSTEM;
D O I
10.1016/j.bmc.2022.116814
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We report four dinuclear silver(I) and gold(I) complexes containing two different bidentate N-heterocyclic carbene ligands (bisNHC). One of these complexes 4, shows strong and selective anticancer activity against the human ovarian cancer cell line A2780. Mechanistically, 4 enhances the oxidative stress by stimulating reactive oxygen species production and inhibiting the scavenging activity of thioredoxin reductase. Our findings provide evidence that tuning ligand and electronic properties of metal-NHC complexes can modulate their reactivity and selectivity and it may result in potential novel anticancer drugs.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Dinuclear Rhenium(I) Tricarbonyl Complexes as Anticancer Drug Candidates
    Montesdeoca, Nicolas
    Borkar, Reema L.
    Sathiyendiran, Malaichamy
    Karges, Johannes
    CHEMISTRY-A EUROPEAN JOURNAL, 2024, 30 (32)
  • [2] Macrocyclic dinuclear gold(I) and silver(I) NHCs complexes
    Wang, JW
    Song, HB
    Li, QS
    Xu, FB
    Zhang, ZZ
    INORGANICA CHIMICA ACTA, 2005, 358 (13) : 3653 - 3658
  • [3] Dinuclear Silver Complexes in Catalysis
    Elkoush, Tasneem
    Reich, Natasha D.
    Campbell, Michael G.
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2021, 60 (42) : 22614 - 22622
  • [4] From coins to cancer therapy: Gold, silver and copper complexes targeting human topoisomerases
    Ceramella, Jessica
    Mariconda, Annaluisa
    Iacopetta, Domenico
    Saturnino, Carmela
    Barbarossa, Alexia
    Caruso, Anna
    Rosano, Camillo
    Sinicropi, Maria Stefania
    Longo, Pasquale
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2020, 30 (03)
  • [5] Dinuclear silver(I) and gold(I) complexes with chiral oxazoline-NHC ligands
    Hoffmann, Marie
    Dagorne, Samuel
    Pale, Patrick
    Blanc, Aurelien
    de Fremont, Pierre
    JOURNAL OF ORGANOMETALLIC CHEMISTRY, 2022, 979
  • [6] Dinuclear μ-fluoro cations of copper, silver and gold
    Wyss, Chelsea M.
    Tate, Brandon K.
    Bacsa, John
    Wieliczko, Marika
    Sadighi, Joseph P.
    POLYHEDRON, 2014, 84 : 87 - 95
  • [7] Recent advances in iron-complexes as drug candidates for cancer therapy: reactivity, mechanism of action and metabolites
    Bouche, Mathilde
    Hognon, Cecilia
    Grandemange, Stephanie
    Monari, Antonio
    Gros, Philippe C.
    DALTON TRANSACTIONS, 2020, 49 (33) : 11451 - 11466
  • [8] Dinuclear Gold Diselenophosphate Complexes: Structures and Photoluminescence
    You, Hong-Jhin
    Fang, Ching-Shiang
    Lin, Ju-Ling
    Sun, Shih-Sheng
    Liu, C. W.
    INORGANIC CHEMISTRY, 2010, 49 (17) : 7641 - 7643
  • [9] Therapeutic Pretargeting with Gold Nanoparticles as Drug Candidates for Boron Neutron Capture Therapy
    Feiner, Irene V. J.
    Pulagam, Krishna R.
    Gomez-Vallejo, Vanessa
    Zamacola, Kepa
    Baz, Zurine
    Caffarel, Maria M.
    Lawrie, Charles H.
    Ruiz-de-Angulo, Ane
    Carril, Monica
    Llop, Jordi
    PARTICLE & PARTICLE SYSTEMS CHARACTERIZATION, 2020, 37 (12)
  • [10] Gold Nanoparticles for Drug Delivery and Cancer Therapy
    Siddique, Sarkar
    Chow, James C. L.
    APPLIED SCIENCES-BASEL, 2020, 10 (11):